Novavax, Inc. (NVAX) Offers to Buy All Outstanding Shares of Isconova for $29.6 Million
6/4/2013 9:31:57 AM
More...
|
Isconova to Present at "Influenza Vaccines for the World Conference"
10/11/2012 10:59:19 AM
More...
|
Isconova's Adjuvant Matrix-M™ in Clinical Trial With Malaria Vaccine
10/8/2012 10:54:37 AM
More...
|
Isconova Carries Out a Fully Guaranteed Rights Issue of Approximately SEK 50 Million
8/27/2012 11:44:31 AM
More...
|
Isconova's Adjuvant Matrix-M Approved by FDA for an IND Clinical Trial
8/15/2012 10:22:59 AM
More...
|
Isconova Concludes Partnership With Virbac S.A. (FR:PVIRP)
7/25/2012 9:40:58 AM
More...
|
Isconova to Present Matrix-M™ Adjuvant at Modern Vaccines Adjuvants & Delivery Systems Conference
6/29/2012 10:29:09 AM
More...
|
Isconova - Interim Report January-March 2012
5/29/2012 10:08:16 AM
More...
|
Successful Phase I Study Using Isconova's Matrix MTM Adjuvant
5/14/2012 10:42:44 AM
More...
|
Isconova (publ.) - Year-end Report January-December 2011
2/28/2012 9:33:36 AM
More...
|
|